LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00328588

Enrollment

Registered

2006-05-22

Start date

2006-12-31

Completion date

2007-03-31

Last updated

2008-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer of Lung, Cancer of the Lung, Carcinoma, Non-Small Cell Lung, Lung Cancer, Non-Small Cell Lung Carcinoma

Keywords

Treatment Efficacy, Treatment Effectiveness, Disease Management, Treatment, Safety

Brief summary

A study for the treatment of Non-Small Cell Lung Cancer (NSCLC) in patients previously treated with chemotherapy.

Interventions

DRUGYM155

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Histologically or cytologically confirmed non-small cell lung cancer. * Prior chemotherapy regimen(s) for lung cancer

Exclusion criteria

* History of other malignancy in the last 5 years * Major surgery within the past 21 days

Design outcomes

Primary

Measure	Time frame
Tumor response rate (CR+PR)	In first 6 cycles

Countries

Czechia, Germany, Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026